A Pilot Phase II, Single Arm, Open Label, Investigator-initiated Clinical Trial of Regorafenib Plus 5-Fluorouracil/Leucovorin (5FU/LV) Beyond Progression on Regorafenib Monotherapy in Metastatic Colorectal Cancer (mCRC)
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 16 Nov 2017 Status changed from not yet recruiting to recruiting.
- 28 Jul 2017 Planned initiation date changed from 30 Jun 2017 to 30 Oct 2017.
- 07 Apr 2017 New trial record